Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Short-term Investments (2015 - 2026)

Xencor (XNCR) posted quarterly Short-term Investments of $370.2 million for Q1 2026, up 657.53% year-over-year from $48.9 million in Q1 2025, and down 2.87% quarter-over-quarter from $381.2 million in Q4 2025.

Analysis

Xencor (XNCR) Short-term Investments (2015 - 2026) Analysis & Trends

Xencor (XNCR) has reported Short-term Investments for 12 consecutive years, with $370.2 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Short-term Investments rose 657.53% year-over-year to $370.2 million; the TTM figure through Mar 2026 stood at $370.2 million (up 657.53% YoY), while the FY2025 annual figure was $381.2 million, down 6.8% from the prior year.
  • Short-term Investments eased to $370.2 million in Q1 2026 per XNCR's latest filing, from $381.2 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $497.7 million in Q4 2023 and bottomed at $26.9 million in Q2 2022.
  • Historically, Short-term Investments has averaged $193.3 million across 5 years, with a median of $48.9 million in 2025.
  • Annual changes were most pronounced in 2022 — Short-term Investments plunged 90.94% — and 2023, when it surged 1182.71%.
  • Xencor's Short-term Investments stood at $42.4 million in 2022, then surged by 1073.02% to $497.7 million in 2023, then retreated by 17.83% to $409.0 million in 2024, then decreased by 6.8% to $381.2 million in 2025, then dropped by 2.87% to $370.2 million in 2026.
  • Business Quant data shows XNCR's Short-term Investments at $370.2 million in Q1 2026, $381.2 million in Q4 2025, and $84.3 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Xencor 2.02 Bn 1.65 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 333.15 Mn
Mar 31, 2026 370.21 Mn
Dec 31, 2025 381.16 Mn
Sep 30, 2025 358.49 Mn
Jun 30, 2025 358.98 Mn
Mar 31, 2025 381.02 Mn
Dec 31, 2024 408.97 Mn
Sep 30, 2024 435.04 Mn
Jun 30, 2024 449.37 Mn
Mar 31, 2024 460.37 Mn
Dec 31, 2023 497.73 Mn
Sep 30, 2023 412.83 Mn
Jun 30, 2023 476.67 Mn
Mar 31, 2023 475.92 Mn
Dec 31, 2022 526.69 Mn
Sep 30, 2022 515.40 Mn
Jun 30, 2022 435.62 Mn
Mar 31, 2022 278.06 Mn
Dec 31, 2021 153.77 Mn
Sep 30, 2021 199.42 Mn